WALDENCAST ACQUISITION CORP.
10 Bank Street, Suite 560
White Plains, NY 10606
July 1, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: | Lynn Dicker |
Jenn Do | |
Jane Park | |
Dorrie Yale | |
Division of Corporation Finance | |
Office of Life Sciences | |
RE: | Waldencast Acquisition Corp. (the “Company”) |
Registration Statement on Form F-4 | |
File No. 333-262692 |
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date of the Company’s Registration Statement on Form F-4 (File No. 333-262692) be accelerated by the Securities and Exchange Commission to 4:30 p.m. Washington D.C. time on July 6, 2022, or as soon as practicable thereafter.
We request that we be notified of such effectiveness by a telephone call to Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP at (212) 735-2297 and that such effectiveness also be confirmed in writing.
Very truly yours, | |||
Waldencast Acquisition Corp. | |||
By: | /s/ Michel Brousset | ||
Name: | Michel Brousset | ||
Title: | Chief Executive Officer |
cc: | Maxim O. Mayer-Cesiano |
Skadden, Arps, Slate, Meagher & Flom LLP |